Диссертация (Иммуноморфологические ассоциации инфекции helicobacter pylori с показателями воспаления и дисфункции эндотелия в оценке течения и прогноза ишемической болезни сердца), страница 69

– 2004. – N 109. – P. 27-33.374. Larsen E. PADGEM protein: a receptor that mediates the interaction of activatedplatelets with neutrophils and monocytes / E. Larsen, A. Celi, G.E. Gilbert et all //Cell. – 1989. – N 59. – P. 305-12.375. Larsson P.T. Circulating markers of inflammation are related to carotid artery atherosclerosis / P.T. Larsson, S. Hallerstam, S. Rosfors et all // Int. Angiol.

– 2005. –Vol. 24, N l. – P. 43-51.376. Laurila A. Association of Helicobacter pylori infection with elevated serum lipids /A. Laurila, A. Bloigu, S. Nayha // Atherosclerosis. – 1999. – Vol. 142, N 1. – P.207-10.377. Lawson C. ICAM-1 signaling in endothelial cells / C. Lawson, S. Wolf //Pharmacol. Rep. – 2009. – Vol. 61, N 1. – P.

22-32.392378. Lee D-H. Association between serum gamma-glutamyltransferase and C-reactiveprotein / D-H. Lee, D.R. Jacobs // Atherosclerosis. – 2005. – Vol. 178, N 2. – P.327-30.379. Lee H.S. TNF-activates death pathway in human aorta smooth muscle cell in thepresence of 7-ketocholesterol / H.S. Lee, J.S. Chang, J.A. Baek et all // Biochemicaland Biophysical Research Communications. – 2005. – Vol. 333, N 4. – P.

1093-99.380. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis / N. Leitinger // Curr. Opin. Lipidol. – 2003. – N 14. – P. 421-30.381. Lenzi C. H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease / C. Lenzi, A. Palazzuoli, N. Giordanoet all // World J. Gastroenterol. – 2006. – N 12. – P. 7815-20.382. Ley K. Getting to the site of inflammation: the leukocyte adhesion cascade updated/ K.

Ley, C. Laudanna, M.I. Cybulsky, S. Nourshargh // Nat Rev Immunol. – 2007. –Vol. 7, N 9. – P. 678-89.383. Li J.J. Inflammation: an important mechanism for different clinical entities of coronary artery diseases / J.J. Li // Chin. Med. J. – 2005.

– N 118. – P. 1817-26.384. Li Y. Free cholesterol-loaded macrophages are an abundant source of tumornecrosis factor-alpha and interleukin-6: model of NF-kappaB- and MAP kinasedependent inflammation in advanced atherosclerosis / Y. Li, R.F. Schwabe, T.DeVries-Seimon, P.M. Yao et all // J. Biol. Chem. – 2005. – N 280. – P. 21763-72.385. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation,thrombosis and stabilization / P.

Libby // Am. J. Cardiol. – 2000. – N 86 (Suppl). –P. 3J-9J.386. Libby P. The molecular bases of the acute coronary syndromes / P. Libby // Circulation. – 1995. – N 91. – P. 2844-50.387. Libby P. Roles of infectious agents in atherosclerosis and restenosis: an assessmentof the evidence and need for future research / P.

Libby, D. Egan, S. Skarlatos // Circulation. – 1997. – N 96. – P. 4095-103.393388. Libby P. Diversity of denizens of the atherosclerotic plaque: not all monocytes arecreated equal / P. Libby, M. Nahrendorf, M.J. Pittet, F.K. Swirski // Circulation. –2008. – N 117. – P. 3168-70.389. Libby P. Inflammation in atherosclerosis: transition from theory to practice / P.Libby, Y.

Okamoto, V.Z. Rocha, Е. Folco // Circ. J. – 2010. – N 74. – P. 213-20.390. Libby P. Mast cells as mediators and modulators of atherogenesis / P. Libby, G.P.Shi // Circulation. – 2007. – N 115. – P. 2471-73.391. Libby Р. Current concepts of the pathogenesis of the acute coronary syndromes / P.Libby // Circulation. – 2001. – N 104. – P. 365-72.392. Libby Р. Vascular biology of atherosclerosis: overview and state of the art / P.Libby // Am. J. Cardiol. – 2003. – N 91 (suppl.).

– P. 3А-6А.393. Libby Р. Inflammation and atherosclerosis / Р. Libby, Р.М. Ridker, A. Maseri //Circulation. – 2002. – N 105. – P. 1135-43.394. Linden S. Role of ABO secretor status in mucosal innate immunity and H. pyloriinfection / S. Linden, J. Mahdavi, C. Semino-Mora, C. Olsen et all // PLoS. Pathog.– 2008.

– N 4. – P. e2-9.395. Lindhal B. Markers of myocardial damage and inflammation in relation to longterm mortality in unstable coronary artery disease / B. Lindhal, H. Toss, A. Siegbahn, P. Venge, L. Wallentin // N. Engl. J. Med. – 2000. – N 343. – P. 1139-47.396. Lindholm C. Induction of chemokine and cytokine responses by Helicobacter pylori in human stomach explants / C. Lindholm, M. Quiding-Jarbrink, H. Lonroth,A.M. Svennerholm // Scand. J. Gastroenterol. – 2001.

– Vol. 10, N 36. – P. 1022-29.397. Lindholm С. Local cytokine response in Helicobacter pylori-infected subjects / C.Lindholm, M. Quiding-Jarbrink, H. Lonroth et all // Infect. and Immun. – 1998. – N66. – P. 5964-71.398. Lindsberg P.J. Inflammation and infections as risk factors for ischemic stroke / P.J.Lindsberg, A.J. Grau // Stroke. – 2003.

– N 34. – P. 2518-32.394399. Liptay M.J. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries / M.J. Liptay, W.C. Parks, R.P.Mecham et all // J. Clin. Invest. – 1993. – N 91. – P. 588-94.400. Liuzzo G. The prognostic value of C-reactive protein and serum amyloid A in severe unstable angina / G.

Liuzzo, L.M. Biasucci, J.R. Gallimore et all // Circulation.– 1996. – N 94. – P. 2373-80.401. Lo Presti R. Polymorphonuclear leukocyte integrine profile in vascular atherosclerotic disease / R. Lo Presti, B. Canino, M. Montana // Clin.

Hemorheol. Microcirc. –2004. – Vol. 30, N 1. – P. 53-60.402. Locatelli A. Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease / A. Locatelli, W.R. Catapani, C.R.JrGomes et all // World J. Gastroenterol. – 2004. – Vol. 20, N 10. – P. 2997-3000.403. Lowe G.D. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa inprediction of coronary heart disease / G.D. Lowe, A. Rumley, A.D.

McMahon et all// Arterioscler. Thromb. Vasc. Biol. – 2004. – N 24. – P. 1529-34.404. Lower G.D.О. С-reactive protein, fibrin D-dimer, and risk of ischemic heart disease. The Caerphilly and Speedwell Studies / G.D.О. Lower, P.М. Sweetham,J.W.G. Yarnell et all // Arterioscler. Thromb. Vasс. Biol. – 2004. – Vol. 24, N 10.

–P. 1957-62.405. Luc G. PRIME Study Group. С-reactive protein, interleukin-6, and fibrinogen aspredictors of coronary heart disease: the PRIME Study / G. Luc, J.М. Ваrd, I. JuhanVague et all // Arterioscler. Thromb. Vasc. Biol. – 2003. – N 23. – P. 1255-61.406. Luo L.N. Relation between Helicobacter pylori infection and coronary heart disease / L.N. Luo, W.D.

Zhu, Z.P. Fan et all // Acta Acad. Med. Suzhou (Chin). –2001. – N 21. – P. 156-58.407. Lusher T.F. Biology of the endothelium / T.F. Lusher, M. Barton // Clin. Cardiol. –1997. – N 10 (suppl 11). – P. II3-II10.395408. Luzza F. Up-regulation of IL-17 is associated with bioactive IL-8 expression inHelicobacter pylori infected human gastric mucosa / F. Luzza, T. Parrello, G.Monteleone et all // J. Immunol. – 2000. – N 165. – P. 5332-37.409. Maeda S.

Distinct mechanism of Helicobacter pylori-mediated NF-кВ activationbetween gastric cancer cells and monocytic cells / S. Maeda, М. Akanuma, Y.Mitsuno et all // J. Biol. Chem. – 2001. – N 276. – P. 44856-64.410. Majka J. Influence of chronic Helicobacter pylori infection on ischemic cerebralstroke risk factors / J. Majka, T. Rog, P.C.

Konturek // Med. Sci. Monit. – 2002. – N10. – P. 675-84.411. Malfertheiner P. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2 – 2000 consensus report / P. Malfertheiner, F. Megraud, С.О’Morain et all // Aliment. Pharmacol. Ther. – 2002. – N 16. – P. 167-80.412. Malfertheiner P. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report / P.

Malfertheiner, F. Megraud, С.О’Morain et all // Gut. – 2007. – N 56. – P. 772-81.413. Mallat Z. Protective role of IL-10 in atherosclerosis / Z. Mallat, S. Besnard, M.Duriez et all // Circ. Res. – 1999. – N 85. – P. e17-24.414. Mallat Z. Expression of IL-18 in human atherosclerotic plaque and relation toplaque instability / Z. Mallat, A. Corbaz, A. Scoazec et all // Circulation. 2001. – N104.

– P. 1598-603.415. Mallat Z. IL-18/IL-18 binding protein signaling modulates atherosclerotic lesiondevelopment and stability / Z. Mallat, A. Corbaz, A. Scoazec et all // Circ. Res. –2001. – N 89. – P. e41-45.416. Mallat Z. The role of adaptive T cell immunity in atherosclerosis / Z. Mallat, S.Taleb, H. Ait-Oufella, A. Tedgui // J. Lipid. Res.

– 2009. – N 50. – P. S364-S369.417. Manolakis A. A review of the postulated mechanisms concerning the associationof Helicobacter pylori with ischemic heart disease / A. Manolakis, A.N.Kapsoritakis, S.P. Potamianos // Helicobacter. – 2007. – N 12. – P.

287-97.396418. Marcus J. Homocysteine lowering and cardiovascular disease risk: lost in translation / J. Marcus, M.J. Sarnak, V. Menon // Can. J. Cardiol. – 2007. – Vol. 23, N 9. –P. 707-10.419. Markus H.S. Helicobacter pylori: a risk factor for ischaemic cerebrovascular disease and carotid atheroma / H.S. Markus, M.A. Mendall // J. Neurol.

Neurosurg.Psychiat. – 1998. – N 64, – P. 104-107.420. Markus H.S. Helicobacter pylori infection, the cytotoxin gene A strain, and carotidartery intima-media thickness / H.S. Markus, P. Risley, M.A. Mendall et all // J.Cardiovasc. Risk. – 2002. – N 9. – P. 1-6.421. Marra M. Asymptomatic Helicobacter pylori infection increases asymmetricdimethylarginine levels in healthy subjects / M. Marra, A.R. Bonfigli, P. Bonazzi etall // Helicobacter. – 2005.

– N 10. – P. 609-14.422. Marshal J.S. Novel cellular interactions and networks involving the intestinal immune system and its microenvironment / J.S. Marshal, J. Bienenstock, М.H. Perdueet аll // Acta path. microbiol. scand. – 1989. – Vol. 97, N 1-6. – P. 383-394.423. Marshall В.J. The relation of Helicobacter pylori to gastric adenocarcinoma andlymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention / В.J. Marshall, Н.M. Windsor // Med.